Dana specializes in neurodevelopmental and neurodegenerative disorders, muscular dystrophies, congenital disorders of glycosylation, and lysosomal storage diseases. With broad academic and translational research experience, she leads programs from novel model development and characterization through IND-enabling therapeutic studies. Dana is motivated by the urgent need to bring new therapies to families affected by rare disease.
Dana received her B.S. in biochemistry from Roanoke College in Virginia. She then studied the neuropathology underlying sensory dysfunction in a female mouse model of Rett syndrome at the University of Tennessee for her graduate work. Dana completed her postdoctoral work at the Children’s Hospital of Philadelphia characterizing monogenic neurodevelopmental and neurodegenerative mouse models before joining the JAX Rare Disease Translational Center.